Applying mRNA Vaccine Technology to HIV/AIDS

https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/a6/af/f5/a6aff53f-e015-a8ef-2a8c-c3adbd959cb3/mza_6316585078050322705.jpg/600x600bb.jpg

COVID-19: On The Frontlines

ReachMD

94 episodes

6 months ago

In March 2020, the World Health Organization officially declared the SARS-COV-2 infection outbreak a global pandemic, spurring one of the greatest public health crises and education efforts in recent history. And while there have been several victories in the battle against this global pandemic, such as the widespread adoption of telehealth and the development of COVID-19 vaccines, many questions still remain. That’s why our COVID-19: On the Frontlines series features infectious disease physicians and public health education experts from around the world to bring you the latest news on COVID-19 vaccines, clinical practice updates, and research from clinical trials so that we can continue to keep our patients safe amid this global pandemic and beyond.

Science

Medicine

RSS

All content for COVID-19: On The Frontlines is the property of ReachMD and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Science

Medicine

Applying mRNA Vaccine Technology to HIV/AIDS

COVID-19: On The Frontlines

3 years ago

Applying mRNA Vaccine Technology to HIV/AIDS

Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Chris Beyrer, MD, MPH

Amid the ongoing COVID-19 pandemic, countries in Sub-Saharan Africa are also facing high rates of HIV and AIDS prevalence. But after the success of the mRNA COVID-19 vaccines, could an mRNA vaccine for HIV/AIDS be on the horizon? Here to explore emerging research and the potential role that mRNA technology might have in battling this global epidemic is Dr. Chris Beyrer, a Professor of Epidemiology at the Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland.